Colonial Trust Advisors Becton Dickinson & CO Transaction History

Colonial Trust Advisors

  • $1.14 Billion
  • Q3 2024

A detailed history of Colonial Trust Advisors transactions in Becton Dickinson & CO stock. As of the latest transaction made, Colonial Trust Advisors holds 3,519 shares of BDX stock, worth $801,205. This represents 0.07% of its overall portfolio holdings.

Number of Shares
3,519
Previous 3,817 7.81%
Holding current value
$801,205
Previous $892,000 4.93%
% of portfolio
0.07%
Previous 0.09%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$221.47 - $242.41 $65,998 - $72,238
-298 Reduced 7.81%
3,519 $848,000
Q2 2024

Aug 14, 2024
SELL
$225.07 - $246.17 $116,361 - $127,269
-517 Reduced 11.93%
3,817 $892,000
Q1 2024

May 13, 2024
SELL
$233.45 - $247.73 $379,122 - $402,313
-1,624 Reduced 27.26%
4,334 $1.07 Million
Q4 2023

Feb 14, 2024
SELL
$232.24 - $267.23 $494,438 - $568,932
-2,129 Reduced 26.33%
5,958 $1.45 Million
Q3 2023

Nov 13, 2023
SELL
$254.9 - $283.59 $46,646 - $51,896
-183 Reduced 2.21%
8,087 $2.09 Million
Q2 2023

Aug 14, 2023
SELL
$238.39 - $265.32 $249,594 - $277,790
-1,047 Reduced 11.24%
8,270 $2.18 Million
Q1 2023

May 11, 2023
SELL
$229.71 - $259.35 $51,684 - $58,353
-225 Reduced 2.36%
9,317 $2.31 Million
Q4 2022

Feb 14, 2023
BUY
$218.29 - $256.91 $23,575 - $27,746
108 Added 1.14%
9,542 $2.43 Million
Q3 2022

Nov 14, 2022
BUY
$51.03 - $264.23 $49,141 - $254,453
963 Added 11.37%
9,434 $2.1 Million
Q2 2022

Aug 12, 2022
SELL
$234.74 - $275.42 $30,516 - $35,804
-130 Reduced 1.51%
8,471 $2.09 Million
Q1 2022

May 09, 2022
SELL
$243.64 - $270.48 $102,816 - $114,142
-422 Reduced 4.68%
8,601 $2.29 Million
Q4 2021

Feb 14, 2022
SELL
$230.08 - $250.94 $86,970 - $94,855
-378 Reduced 4.02%
9,023 $2.27 Million
Q3 2021

Nov 12, 2021
SELL
$232.72 - $256.47 $141,726 - $156,190
-609 Reduced 6.08%
9,401 $2.31 Million
Q2 2021

Aug 05, 2021
SELL
$232.65 - $254.58 $312,681 - $342,155
-1,344 Reduced 11.84%
10,010 $2.43 Million
Q1 2021

May 10, 2021
SELL
$232.09 - $256.88 $19,495 - $21,577
-84 Reduced 0.73%
11,354 $2.76 Million
Q4 2020

Jan 29, 2021
BUY
$221.92 - $245.94 $16,422 - $18,199
74 Added 0.65%
11,438 $2.86 Million
Q3 2020

Oct 26, 2020
SELL
$215.77 - $276.76 $27,187 - $34,871
-126 Reduced 1.1%
11,364 $2.64 Million
Q2 2020

Aug 10, 2020
BUY
$219.9 - $263.41 $104,672 - $125,383
476 Added 4.32%
11,490 $2.75 Million
Q1 2020

May 06, 2020
BUY
$195.69 - $279.01 $22,504 - $32,086
115 Added 1.06%
11,014 $2.53 Million
Q4 2019

Feb 14, 2020
SELL
$236.45 - $266.82 $29,556 - $33,352
-125 Reduced 1.13%
10,899 $2.96 Million
Q3 2019

Nov 15, 2019
SELL
$230.58 - $256.08 $6,686 - $7,426
-29 Reduced 0.26%
11,024 $2.79 Million
Q2 2019

Aug 21, 2019
BUY
$217.4 - $246.08 $24,783 - $28,053
114 Added 1.04%
11,053 $2.79 Million
Q1 2019

May 15, 2019
BUY
$206.05 - $248.17 $125,690 - $151,383
610 Added 5.91%
10,939 $2.73 Million
Q4 2018

Feb 12, 2019
SELL
$204.73 - $257.93 $21,496 - $27,082
-105 Reduced 1.01%
10,329 $2.33 Million
Q3 2018

Nov 14, 2018
BUY
$233.07 - $256.0 $32,629 - $35,840
140 Added 1.36%
10,434 $2.72 Million
Q2 2018

Aug 14, 2018
BUY
$208.1 - $233.85 $28,093 - $31,569
135 Added 1.33%
10,294 $2.47 Million
Q1 2018

May 10, 2018
BUY
$205.46 - $240.27 $1.38 Million - $1.61 Million
6,719 Added 195.32%
10,159 $2.2 Million
Q4 2017

Feb 21, 2018
BUY
$189.0 - $222.64 $44,415 - $52,320
235 Added 7.33%
3,440 $736,000
Q3 2017

Nov 14, 2017
BUY
$186.89 - $198.9 $1,868 - $1,989
10 Added 0.31%
3,205 $628,000
Q2 2017

Aug 14, 2017
BUY
N/A
3,195
3,195 $623,000

Others Institutions Holding BDX

# of Institutions
1,738
Shares Held
249M
Call Options Held
690K
Put Options Held
787K
View Full List

About BECTON DICKINSON & CO

BDX Quotes by TradingView
  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $64.9B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Colonial Trust Advisors Portfolio

Follow Colonial Trust Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Colonial Trust Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Colonial Trust Advisors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email